Monday morning brought news that Pfizer’s coronavirus vaccine trials have shown more than a 90% efficacy, meaning that FDA approval for public distribution could come by the end of the month. It’s estimated that at least 50 million doses could be available by the end of the year, with another 1.3 billion coming in 2021, which would be a huge step forward in the eventual eradication of the virus. Okay, but what does that have to do with the Cubs?
Potentially a lot, specifically if the presence of a vaccine leads to a return to normalcy in terms of full stadiums, bars, etc.